A new study reports a potential new treatment for seizures which often occur in children with genetic metabolic disorders and people with liver failure.
Researchers have identified a reduced exchange of glutamine between astrocytes and neurons in a new Huntington's disease study.
··1 min read
Researchers identified 21 proteins that specifically bind to a protein called ataxin-1. Twelve of these proteins enhance the misfolding of ataxin-1 and thus promote the formation of harmful protein aggregate structures, whereas nine of them prevent the misfolding.
Researchers find a single gene which encodes two separate proteins from the same sequence of messenger RNA. The finding could provide new strategies for treating SCA6.
Researchers discover a novel factor which suppresses misfolding and aggregation of the huntingtin protein.
Combining an antibiotic drug that targets glutamine with the ketogenic diet helps kill glioblastoma cancer cells, reversing symptoms of the disease and improving survivability in mouse models.
Researchers have developed a new model of mitochondrial epilepsy which captures specific features observed in patients. The new model may help provide better therapies and treatments for the condition.